Table 1 Baseline of 325 patients with breast cancer
| Â | Total | CADM3 LOW | CADM3 High | p-value |
|---|---|---|---|---|
All patients | 325 | 163 | 162 | Â |
Age | Â | Â | Â | <0.001 |
≤ 60 | 265(81.5) | 120(73.6) | 145(89.5) |  |
>60 | 60(18.5) | 43(26.4) | 17(10.5) | Â |
PAM50 | Â | Â | Â | <0.001 |
LumA | 96(29.5) | 28(17.2) | 68(42.0)* | Â |
LumB | 121(37.2) | 62(38.0) | 59(36.4) | Â |
Her2 | 44(13.5) | 23(14.1) | 21(13.0) | Â |
Basal | 64(19.7) | 50(30.7) | 14(8.6)* | Â |
Surgical Method | Â | Â | Â | 0.402 |
Mastectomy | 312(96.0) | 155(95.1) | 157(96.9) | Â |
BCS | 13(4.0) | 8(4.9) | 5(3.1) | Â |
T stage | Â | Â | Â | 0.046 |
Tis | 9(2.8) | 3(1.8) | 6(3.7) | Â |
T1 | 78(24.0) | 31(19.0) | 47(29.0)* | Â |
T2 | 208(64.0) | 116(71.2) | 92(56.8)* | Â |
T3 | 24(7.4) | 12(7.4) | 12(7.4) | Â |
T4 | 6(1.8) | 1(0.6) | 5(3.1) | Â |
N stage | Â | Â | Â | 0.951 |
N0 | 215(66.2) | 107(65.6) | 108(66.7) | Â |
N1 | 75(23.1) | 37(22.7) | 38(23.5) | Â |
N2 | 21(6.5) | 11(6.7) | 10(6.2) | Â |
N3 | 14(4.3) | 8(4.9) | 6(3.7) | Â |
M stage | Â | Â | Â | 0.179 |
M0 | 320(98.5) | 159(97.5) | 161(99.4) | Â |
M1 | 5(1.5) | 4(2.5) | 1(0.6) | Â |